FDA approves Mylan bronchospasm drug
PITTSBURGH — The Food and Drug Administration has approved a generic treatment for bronchospasm made by Mylan, the drug maker said Monday.
Mylan announced the approval of levalbuterol inhalation solution in the 0.31 mg/3 mL, 0.63 mg/3 mL and 1.25 mg/3 mL strengths. The company has begun shipping the product.
The drug is a generic version of Sunovion’s Xopenex inhalation solution, which is used to treat bronchospasm in patients ages 6 years and older with reversible obstructive airway disease.
Various versions of the drug had sales of $438.8 million in 2012, according to IMS Health.
CARE Pharmacies names new director of operations
LINTHICUM, Md. — CARE Pharmacies on Monday announced the addition of Mark Ey to their corporate team as director of operations.
“We are very excited to have him lead our operations team,” stated CARE CEO Michael Wysong. “Mark’s unique background coupled with his longstanding track record of success make him a perfect fit to oversee our growing operational footprint.”
Before joining CARE, Mark was an area manager with NeighborCare Pharmacies overseeing the operations for multiple sites throughout the mid-Atlantic. Prior to NeighborCare, he was an independent pharmacy manager with Freedom Pharmacies in Baltimore.
Ey is a graduate of the University of Maryland School of Pharmacy. He was a GlaxoSMithKline Executive Management for Pharmacy Leaders Fellow and has also served as an advisory board member for the Executive Management Program at the Leonard Davis Institute, Wharton School of Business. Ey currently serves as a clinical assistant professor at University of Maryland School of Pharmacy and a pharmacist volunteer for the Maryland Professional Volunteer Corps.
NACDS endorses bipartisan Senate bill to expand MTM services for seniors
WASHINGTON — The National Association of Chain Drug Stores (NACDS) today applauded the introduction of S. 557, the Medication Therapy Management Empowerment Act of 2013, introduced yesterday by U.S. Sens. Kay Hagan, D-N.C., and Pat Roberts, R-Kan., along with the support of original cosponsors U.S. Sens. Sherrod Brown, D-Ohio, Al Franken, D-Minn., Tim Johnson, D-S.D., and Amy Klobuchar, D-Minn. The legislation seeks to expand access to MTM services for senior citizens enrolled in the Medicare program.
“NACDS appreciates the leadership of Sens. Hagan and Roberts in spearheading this commonsense legislation, as well as the support of original cosponsors Sens. Brown, Franken, Johnson and Klobuchar. This bill can help patients understand the importance of taking their medications as prescribed,” said NACDS President and CEO Steve Anderson, IOM, CAE. “Innovative pharmacy services such as MTM help to improve patient health and healthcare affordability, especially for those suffering from chronic conditions such as diabetes, hypertension, asthma and other conditions.”
Medication therapy management (MTM) is a professional service offered by pharmacists and other qualified health practitioners that helps ensure medications are taken appropriately to help improve health, reduce the risk of adverse events, and help control healthcare costs. Congress created the MTM benefit under the Medicare Modernization Act of 2003 for Medicare beneficiaries by requiring MTM services for patients on multiple medications suffering from chronic conditions or diseases.
"Medication Therapy Management is the type of commonsense, fiscally responsible program that should be expanded to benefit more seniors," said Sen. Hagan. "In North Carolina, this program has saved tens of millions of dollars, but more importantly, it has helped keep seniors healthy. I will continue working with my colleagues on both sides of the aisle to expand this program to more seniors so that we can keep improving health outcomes without increasing health costs."
“We have recognized the value of pharmacists in the health system for many years. They are especially valuable for our Kansas communities, and can sometimes be the only health provider in our rural towns.” said Sen. Roberts. “MTM is an important tool in the pharmacists tool box for many patients but which can be critical for those suffering from chronic conditions. The Medication Therapy Management Empowerment Act gives patients access to valuable counseling and management for their conditions, and takes the essential steps to guarantee what we already know: that MTM will save the system money while providing higher quality care for patients. I urge my colleagues to support this bipartisan legislation.”
Health policy research group NEHI cites that only 50 percent of patients take their medications properly as prescribed by their doctor, which costs the nation more than $290 billion annually in avoidable health spending annually.